Bloomberg American Health Initiative - Fentanyl FORECAST Study
An informational page on the Bloomberg American Health Initiative website which details facts and resources from their Fentanyl Overdose Reduction Checking Analysis Study (FORECAST).
This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 [PDF 0.69 MB] and Volume 2 [PDF 1.28 MB] of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.
An informational page on the Bloomberg American Health Initiative website which details facts and resources from their Fentanyl Overdose Reduction Checking Analysis Study (FORECAST).
This implementation guide serves to provide other medical clinics seeking to integrate maternal mental health care into obstetric and/or pediatric settings with best practices for doing so.
Reviews three FDA-approved medications for OUD treatment (methadone, naltrexone, and buprenorphine) and the other strategies and services needed to support people in recovery.
This toolkit provides tools to both providers and patients for the assessment and management of perinatal mood and anxiety disorders, as well as substance use disorders (SUD).
This is an opinion piece that provides background, recommendations, and conclusions for the treatment of pregnant women with opioid use and opioid use disorder, to improve maternal and infant outcomes.